InvestorsHub Logo
Followers 2
Posts 353
Boards Moderated 0
Alias Born 07/13/2007

Re: rickyricks post# 2635

Monday, 01/02/2017 1:36:51 PM

Monday, January 02, 2017 1:36:51 PM

Post# of 3833
The other option is Merck just buys GALT outright with a milestone payment if the CX trial is successful. Similar to the TBRA purchase.

Say $500M initially and another $500M if CX is successful. Just speculating on #s, but you get idea and then Merck can accelerate studies/commercialization and other indications. The GALT team can lead the galectin-3 program.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GALT News